Skip to main content
SpringerLink
Log in

12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

The purpose of this observational study was to investigate the feasibility, initial safety, and efficacy of the SeQuent® Please DCB (B. Braun Melsungen, Germany) for patients with de novo coronary lesions in vessels exceeding 3.0 mm in a consecutive series of all comer percutaneous coronary intervention. A total of 120 patients (135 lesions) with de novo coronary lesions in vessels ≥ 3.0 mm treated with DCB were enrolled in this single-centre prospective observational study. The primary endpoint was target lesion failure (TLF), a composite endpoint of cardiac death, target vessel-myocardial infarction (TV-MI), and clinically driven target vessel revascularization (TLR) at 12 months. Safety endpoints included cardiac death, TV-MI, and definite target vessel thrombosis. 45.9% of the lesions were classified as complex (type B2/C). The reference vessel diameter was 3.09 ± 0.31 mm measured via quantitative coronary angiography analysis. Coronary dissections occurred in 42 patients (35.0%; Type A-B 14.1%; Type C 19.1%; Type D: 1.6%), two of which [1.6%; (type D dissection)] underwent bail-out stent implantation. 12-month follow-up was completed in 100% patients. The 12-month incidence of TLF was 3.4%. The clinically driven TLR occurred in four patients (3.4%). The incidence of TLR was low in patients without any detectable dissections, similar to those with dissections (3.8% vs. 2.5%; p = 0.146). No patient suffered cardiac death, TV-MI, or target vessel thrombosis. The study shows the feasibility, initial safety, and efficacy of coronary intervention using SeQuent® Please DCB for the treatment of patients with de novo lesion in vessels exceeding 3 mm. The study highlights that the coronary dissection (Type A–C) post DCB treatment occurs frequently but is safe at follow up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773–1780

    Article  CAS  PubMed  Google Scholar 

  2. Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221–231

    Article  CAS  PubMed  Google Scholar 

  3. Kereiakes DJ, Yeh RW, Massaro JM et al (2015) Stent thrombosis in drug-eluting or bare-metal stents in patients receiving dual antiplatelet therapy. JACC Cardiovasc Interv 8(12):1552–1562

    Article  PubMed  Google Scholar 

  4. Latib A, Colombo A, Castriota F et al (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60(24):2473–2480

    Article  CAS  PubMed  Google Scholar 

  5. Waksman R, Serra A, Loh JP et al (2013) Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. EuroIntervention 9(5):613–619

    Article  PubMed  Google Scholar 

  6. Nishiyama N, Komatsu T, Kuroyanagi T et al (2016) Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardiol 222:113–118

    Article  PubMed  Google Scholar 

  7. Miglionico M, Mangiacapra F, Nusca A et al (2015) Efficacy and safety of paclitaxel-coated balloon for the treatment of in-stent restenosis in high-risk patients. Am J Cardiol 116(11):1690–1694

    Article  CAS  PubMed  Google Scholar 

  8. López Mínguez JR, Nogales Asensio JM, Doncel Vecino LJ et al (2014) A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results. EuroIntervention 10(1):50–57

    Article  PubMed  Google Scholar 

  9. Belkacemi A, Agostoni P, Nathoe HM et al (2012) First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol 59(25):2327–2337

    Article  PubMed  Google Scholar 

  10. Kleber FX, Rittger H, Bonaventura K et al (2013) Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 102(11):785–797

    Article  CAS  PubMed  Google Scholar 

  11. Sim HW, Ananthakrishna R, Chan SP et al (2018) Treatment of very small de novo coronary artery disease with 2.0 mm drug-coated balloons showed 1-year clinical outcome comparable with 2.0 mm drug-eluting stents. J Invasive Cardiol 30(7):256–261

    PubMed  Google Scholar 

  12. Sinaga DA, Ho HH, Watson TJ et al (2016) Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease. J Interv Cardiol 29(5):454–460

    Article  PubMed  Google Scholar 

  13. Cortese B, Silva Orrego P, Agostoni P et al (2015) Effect of drug-coated balloons in native coronary artery disease left with a dissection. JACC Cardiovasc Interv 8(15):2003–2009

    Article  PubMed  Google Scholar 

  14. Hayıroğlu M, Keskin M, Uzun AO et al. Predictors of in-hospital mortality in patients with ST-segment elevation myocardial Infarction complicated with cardiogenic shock. Heart Lung Circ. 2017

  15. Unverdorben M, Kleber FX, Heuer H et al (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99(3):165–174

    Article  CAS  PubMed  Google Scholar 

  16. Vranckx P, Cutlip DE, Mehran R et al (2010) Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 5(7):871–874

    Article  PubMed  Google Scholar 

  17. Zeymer U, Waliszewski M, Spiecker M et al (2014) Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions. Heart 100(4):311–316

    Article  CAS  PubMed  Google Scholar 

  18. Venetsanos D, Lawesson SS, Panayi G et al. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Catheter Cardiovasc Interv. 2018

  19. Mahmood Zuhdi AS, Zeymer U, Waliszewski M et al (2016) The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective ‘real world’ registry. Springerplus 5:373

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Poerner TC, Duderstadt C, Goebel B, Kretzschmar D, Figulla HR, Otto S (2017) Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography. Clin Res Cardiol 106(1):18–27

    Article  CAS  PubMed  Google Scholar 

  21. Widder JD, Cortese B, Levesque S et al. Coronary artery treatment with an urea-based paclitaxel-coated balloon: the European wide Falcon all comers DCB Registry (FALCON-Registry). EuroIntervention. 2018

  22. Cortese B, Berti S, Biondi-Zoccai G et al (2014) Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv 83(3):427–435

    Article  PubMed  Google Scholar 

  23. Kleber FX, Schulz A, Waliszewski M et al (2015) Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol 104(3):217–225

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all professors and study nurses involved in the DEBATE study.

Funding

This work was financially supported by Program for National Science Funds of China (Grant No. 81730011), National key R & D plan (Grant No. 2018YFA0107400), Program for Changjiang Scholars and Innovative Research Teamin University (Grant No. PCSIRT-14R08).

Author information

Author notes

  1. Yi Liu and Yao-Jun Zhang contributed equally to this article.

Authors and Affiliations

  1. Department of Cardiology, Xijing Hospital, Fourth Military Medical University, No. 15 Changle West Road, Xi’an, 710032, China

    Yi Liu, Long-Xiang Deng, Zhi-Yong Yin, Tao Hu, Qiong Wang, Yan Li, Jia-Yi Li, Wen-Yi Guo, Fang-Jun Mou & Ling Tao

  2. Department of Cardiology, Xuzhou Third People’s Hospital, Xuzhou, China

    Yao-Jun Zhang

Authors
  1. Yi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yao-Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Long-Xiang Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhi-Yong Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tao Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jia-Yi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wen-Yi Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fang-Jun Mou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ling Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All of the authors have read and approved the manuscript.

Corresponding author

Correspondence to Ling Tao.

Ethics declarations

Conflict of interest

All authors declare no conflicts of interest.

Ethical approval

This study was approved by the local ethics committee of our institution.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 34 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Zhang, YJ., Deng, LX. et al. 12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm. Int J Cardiovasc Imaging 35, 579–586 (2019). https://doi.org/10.1007/s10554-018-1505-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-018-1505-z

Keywords

Search

Navigation